Advances in Medicine and Biology. Volume 107

(sharon) #1
Childhood Obesity in the United Kingdom 121

[65] Brufani C, Crinò A, Fintini D, Patera PI, Cappa M, Manco M. 2013.
‘Systematic review of Metformin Use in Obese Nondiabetic Children
and Adolescents’. Horm Res Paediatr. 80:78-85.
[66] Yanovski JA, Krakoff J, Salaita CG, McDuffie JR, Kozlosky M, Sebring
NG, Reynolds JC, Brady SM, Calis KA. 2011. ‘Effects of Metformin on
Body Weight and Body Composition in Obese Insulin Resistant
Children’. Diabetes. 60(2):477-85.
[67] Lustig RH, Hinds PS, Ringwald-Smith K, Christensen RK, Kaste SC,
Schreiber RE, Rai SN, Lensing SY, Wu S, Xiong X. 2003. ‘Octreotide
therapy of pediatric hypothalamic obesity: a double-blind, placebo-
controlled trial’. J Clin Endocrinol Metab. 88(6):2586–92.
[68] Taylor K, Gurney K, Han J, Pencek R, Walsh B, Trautmann M. 2011.
‘Exenatide once weekly treatment maintained improvements in
glycaemic control and weight loss over 2 year’s. BMC Endocr Disord.
11:9.
[69] Kelly AS, Metzig AM, Rudser KD, Fitch AK, Fox CK, Nathan BM,
Deering MM, Schwartz BL, Abuzzahab MJ, Gandrud LM, Moran A,
Billington CJ, Schwarzenberg SJ. 2012. ‘Exenatide as a Weight Loss
Therapy in Extreme Paediatric Obesity A randomized, controlled pilot
study’ Obesity. 20(2):364-70.
[70] Davies MJ, Bergenstal R, Bode B, Kushner RF, Lewin A, Skjøth TV,
Andreasen AH, Jensen CB, DeFronzo RA; NN8022-1922 Study Group.



  1. ‘Efficacy of Liraglutide for Weight Loss Among Patients With
    Type 2 Diabetes: The SCALE Diabetes Randomized Clinical Trial’.
    JAMA. 314(7) 687-99.
    [71] Vilsboll T, Christensen M, Junker AE, Knop FK, Gluud LL. 2012.
    ‘Effects of glucagon-like peptide-1 receptor agonists on weight loss:
    systematic review and meta-analyses of randomised controlled trials’.
    BMJ. 344. doi: 10.1136/bmj.d7771.
    [72] Fox CK, Marlatt KL, Rudser KD, Kelly AS. 2015. ‘Topiramte for
    weight reduction in adolescents with severe obesity’. Clin Pediatr.
    54(1):19-24.
    [73] Bray GA, Hollander P, Klein S, Kushner R, Levy B, Fitchet M, Perry
    BH. 2003. ‘A 6-month randomized, placebo-controlled, dose-ranging
    trial of topiramate for weight loss in obesity’. Obes Res. 11:722-733.
    [74] Astrup A, Caterson I, Zelissen P, et al. 2004. ‘Topiramate, long-term
    maintenance of weight loss induced by a low calorie diet in obese
    subjects’. Obes Res. 12:1658-1669.

Free download pdf